Imagine a common eye drop treatment for nearsightedness causing a rare and unexpected eye misalignment in a child. This is exactly what happened in a recent case report, shedding light on a potential complication of low-dose atropine (LDA) therapy. While LDA has proven effective in slowing the progression of myopia, particularly in children, this case highlights the importance of vigilant monitoring for rare side effects, especially in those with pre-existing binocular vision challenges or high accommodative demands.
Myopia, or nearsightedness, is a growing global concern, affecting an increasing number of children. LDA, specifically 0.01% atropine eye drops, has emerged as a promising intervention to combat this trend by slowing the elongation of the eyeball, a key factor in myopia progression. Its effectiveness and minimal side effects have made it a popular choice for clinicians. However, as with any treatment, rare adverse reactions can occur. This case report details a unique instance where short-term LDA use led to acquired esotropia, a condition where the eyes turn inward, in an 8-year-old boy.
But here's where it gets intriguing: The esotropia resolved completely after discontinuing LDA and switching to multifocal soft contact lenses, raising questions about the interplay between atropine, accommodation, and binocular vision. This case not only underscores the importance of individualized treatment approaches but also prompts further investigation into the potential risks and benefits of LDA, especially in vulnerable populations.
The Case Unfolds:
An 8-year-old boy presented with gradually worsening distance vision in both eyes. His family history revealed high myopia in both parents. Upon examination, his visual acuity was significantly reduced, and his axial length had increased compared to measurements taken six months prior. LDA treatment was initiated due to the rapid progression of myopia. However, after three months of treatment, the child began experiencing binocular double vision. Further examination revealed comitant intermittent esotropia, a condition where the eyes intermittently turn inward, with poor control. Despite minimal axial length progression, the esotropia persisted, prompting a switch to multifocal soft contact lenses. This change led to a remarkable resolution of the esodeviation and restoration of binocular fusion.
And this is the part most people miss: The case highlights the complex relationship between atropine, accommodation, and binocular vision. Atropine, a cycloplegic agent, can interfere with the eye's focusing mechanism, potentially leading to accommodative lag and increased convergence demand, especially in individuals with high myopia. This, coupled with the patient's shorter working distance, likely contributed to the development of esotropia. Multifocal soft contact lenses, by creating peripheral myopic defocus, offer an alternative approach that slows axial elongation while preserving normal accommodation and reducing the risk of binocular vision disorders.
Controversy & Comment Hooks:
This case raises several thought-provoking questions. Is the development of esotropia a dose-dependent effect of atropine, or are there other contributing factors? How common is this complication, and what are the long-term implications for patients? Should clinicians reconsider the use of LDA in children with pre-existing binocular vision issues or high accommodative demands? We invite readers to share their insights and experiences in the comments below.
Conclusion:
While LDA remains a valuable tool in managing progressive myopia, this case serves as a reminder of the importance of individualized treatment plans and close monitoring for potential complications. Further research is needed to fully understand the impact of LDA on binocular vision and to explore alternative myopia control strategies, such as multifocal soft contact lenses, in high-risk populations. By sharing this rare case, we aim to raise awareness and encourage ongoing dialogue among clinicians and researchers in the field of pediatric ophthalmology.
